MoneyWorks4Me

Net sales declined -19.66%  to  Rs. 5595.30 million from Rs. 6964.10 millions.The Net Profit of the company slipped to Rs. 361.40 millions from Rs. 531.70 millions, a decline of -32.03% on QoQ basis.Operating profit for the quarter ended March 2024 decreased to 701.70 millions as compared to 894.50 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5595.30 6964.10 -19.66 22669.10 24979.70 -9.25 22669.10 24979.70 -9.25
Other Income 11.10 9.30 19.35 41.80 22.30 87.44 41.80 22.30 87.44
PBIDT 701.70 894.50 -21.55 2703.10 2846.30 -5.03 2703.10 2846.30 -5.03
Interest 80.90 83.50 -3.11 301.60 325.30 -7.29 301.60 325.30 -7.29
PBDT 620.80 811.00 -23.45 2401.50 2521.00 -4.74 2401.50 2521.00 -4.74
Depreciation 123.40 116.80 5.65 476.70 472.90 0.80 476.70 472.90 0.80
PBT 497.40 694.20 -28.35 1924.80 2048.10 -6.02 1924.80 2048.10 -6.02
TAX 136.00 162.50 -16.31 506.00 520.00 -2.69 506.00 520.00 -2.69
Deferred Tax -15.00 -15.00 0.00 10.00 -12.50 -180.00 10.00 -12.50 -180.00
PAT 361.40 531.70 -32.03 1418.80 1528.10 -7.15 1418.80 1528.10 -7.15
Equity 919.40 926.00 -0.71 919.40 926.00 -0.71 919.40 926.00 -0.71
PBIDTM(%) 12.54 12.84 -2.36 11.92 11.39 4.65 11.92 11.39 4.65
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..